Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

Gastroenterology ◽

10.1053/j.gastro.2010.04.054 ◽

2010 ◽

Vol 139 (2) ◽

pp. 456-463 ◽

Author(s):

Jody Dushay ◽

Patricia C. Chui ◽

Gosala S. Gopalakrishnan ◽

Marta Varela–Rey ◽

Meghan Crawley ◽

...

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver

Download Full-text

Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver Disease

10.1002/hep.30789 ◽

2019 ◽

Vol 70 (5) ◽

pp. 1860-1862 ◽

Author(s):

Jody Dushay ◽

Michelle Lai

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver

Download Full-text

Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events

Journal of the American Heart Association ◽

10.1161/jaha.119.015226 ◽

2020 ◽

Vol 9 (11) ◽

Author(s):

Liang Wu ◽

Lingling Qian ◽

Lei Zhang ◽

Jing Zhang ◽

Jia Zhou ◽

...

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Cardiovascular Events ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver

Download Full-text

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

Journal of Hepatology ◽

10.1016/j.jhep.2010.05.018 ◽

2010 ◽

Vol 53 (5) ◽

pp. 934-940 ◽

Author(s):

Huating Li ◽

Qichen Fang ◽

Fei Gao ◽

Jia Fan ◽

Jian Zhou ◽

...

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Hepatic Triglyceride ◽

Nonalcoholic Fatty Liver

Download Full-text

A Fibroblast Growth Factor 21–Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease

Molecular Pharmacology ◽

10.1124/mol.116.104687 ◽

2016 ◽

Vol 90 (4) ◽

pp. 437-446 ◽

Author(s):

Sarah J. Woolsey ◽

Melanie D. Beaton ◽

Sara E. Mansell ◽

Matilde Leon-Ponte ◽

Janice Yu ◽

...

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Pregnane X Receptor ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver

Download Full-text

Fibroblast Growth Factor Binding Protein 3 A Novel Target for Glucose Intolerance and Nonalcoholic Fatty Liver Disease Treatment

The FASEB Journal ◽

10.1096/fasebj.2018.32.1_supplement.829.5 ◽

2018 ◽

Vol 32 (S1) ◽

Author(s):

Khalid Garman ◽

Elena Tassi ◽

Marcel Schmidt ◽

Anton Wellstein

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth ◽

Disease Treatment ◽

Nonalcoholic Fatty Liver ◽

Download Full-text

Activating AMP‐activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection from Nonalcoholic Fatty Liver Disease in Mice

10.1002/hep.31568 ◽

2020 ◽

Author(s):

Qian Lin ◽

Zhifeng Huang ◽

Genxiang Cai ◽

Xia Fan ◽

Xiaoqing Yan ◽

...

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Protein Kinase ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver ◽

Amp Activated Protein Kinase

Download Full-text

Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)?

Expert Opinion on Investigational Drugs ◽

10.1080/13543784.2020.1718104 ◽

2020 ◽

Vol 29 (2) ◽

pp. 197-204 ◽

Author(s):

Michael Ritchie ◽

Ibrahim A. Hanouneh ◽

Mazen Noureddin ◽

Timothy Rolph ◽

Naim Alkhouri

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Magic Bullet ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver

Download Full-text

Serum Fibroblast Growth Factor-21 Is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Incident Atherosclerotic Cardiovascular Diseases

Diabetes ◽

10.2337/db18-166-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 166-OR

Author(s):

LIANG WU ◽

LINGLING QIAN ◽

HUATING LI ◽

WEIPING JIA

Keyword(s):

Liver Disease ◽

Cardiovascular Diseases ◽

Growth Factor ◽

Fatty Liver ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver ◽

Atherosclerotic Cardiovascular Diseases

Download Full-text

Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease

Medicine ◽

10.1097/md.0000000000020399 ◽

2020 ◽

Vol 99 (22) ◽

pp. e20399 ◽

Author(s):

Atsushi Takahashi ◽

Kazumichi Abe ◽

Masashi Fujita ◽

Manabu Hayashi ◽

Ken Okai ◽

...

Keyword(s):

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Resistance Exercise ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Cytokeratin 18 ◽

Nonalcoholic Fatty Liver

Download Full-text

A novel fibroblast growth factor 1 variant reverses nonalcoholic fatty liver disease in type 2 diabetes.

10.18297/etd/3016 ◽

2018 ◽

Author(s):

Qian Lin

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Growth Factor ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fibroblast Growth Factor ◽

Fatty Liver Disease ◽

Fibroblast Growth ◽

Nonalcoholic Fatty Liver

Download Full-text